ASXL1 and myelodysplastic syndrome: Some gene mutations, such as those in ASXL1, RUNX1, TET2, IDH1, IDH2 and SETBP1, have been considered to be partially responsibility for disease progression in MDS based on the evolutions of mutations in the same individuals whose disease had progression5, 8.